The purpose of this evidenced-based project was to increase chlamydia pre-screening and screening in women under age 25 presenting with urinary symptoms. Interventions included chlamydia pre-screening alerts embedded into the electronic medical record. Three-month evaluation showed a chlamydia pre-screening rate of 100% and an increase in chlamydia screening by 9%.
Introduction

Background
Chlamydia (CHL) is a wide spread sexually transmitted infection (STI) in San Diego county, California, and the nation. CHL is also one of the most commonly reported STIs in the United
States. Females between the ages of 15 and 24 are at the highest risk for infection. Women with CHL are asymptomatic approximately half of the time, often causing women to seek treatment late when serious side effects are present. 1 However, some women do have symptoms of CHL such as cervicitis, abnormal, thick vaginal discharge, bleeding and painful sex. 1, 2 CHL can also cause typical symptoms of a urinary tract infection (UTI) such as dysuria. 3, 4 It is estimated 10 to 50 % of women presenting with UTI symptoms in emergency care settings will have a STI such as CHL if tested. Approximately 10 to 20 % of women with CHL or gonorrhea (GC), if left untreated, will develop PID. Although PID can frequently be treated in an outpatient setting, hospitalizations for PID have increased in the last 10 years adding to overall healthcare costs. The estimated cost in 2012 for a patient with PID was 2,000 dollars, which translates into an annual cost of 1. increase CH screening. 17 Two strategies from that review were included in this EBP project. The intervention strategies included computer alerts for providers in the electronic medical record (EMR) and education workshops for the clinic staff about the importance of CHL screening. In the systematic review, the computer alerts increased screening from 10.6% to 12.2% and the education of staff increased screening from 12.4% to 15.5%.
17
Rationale
The specific trigger to increase CHL screening rates in women presenting to the SHC was the lower CHL screening compliance rate compared to the ACHA's findings. Staff also noted that many women who presented with urinary symptoms were not always screened for CHL.
Additionally, there was no formal template in the electronic medical record (EMR) in dysuria visits to identify CHL screening. Pre-data, from 2015, at the project site indicated there were 320 dysuria visits for women under age 25. About 6% of those dysuria visits had a CHL screening ordered. A total of 129 CHL screenings were ordered during 2015 but not necessarily during dysuria visits. Other visits that had a CHL screening ordered included vaginitis, annual physical, and encounter for STI screening. There were also 3 positive CHL tests in 2015, however these positive tests were not associated with dysuria visits. The decreased CHL screening compliance rates at the project site compared to the ACHA's findings, anecdotal and staff findings prompted the EBP project. The pre-data collected further supported the need for improvement in CHL screening during dysuria visits. Several interventions from the above systematic reviews were utilized in the project to increase CHL screening.
Purpose
The purpose of this EBP project was to increase CHL pre-screening and screening in women under age 25 who presented to the SHC with urinary symptoms over a 3-month period.
Methods
Definitions
In order to increase CHL pre-screening and screening a multifaceted program was implemented. In the context of this EBP project, pre-screening was defined as the process of determining if a patient was indicated for CHL screening. Screening was defined as the actual CHL test ordered.
Interventions
The program implemented had six main components. First, an educational presentation was provided for all clinic staff to understand their role in the EBP project. The educational presentation also emphasized the importance of CHL screening in sexually active women under age 25. Second, an optional pre-visit questionnaire was generated for female patients presenting with urinary symptoms. This questionnaire was available online to female patients who booked an appointment through the online SHC portal. The questionnaire contained a pre-screening assessment template. This template had questions presented in an easy to understand format.
After the patient finished the questionnaire the completed pre-screening assessment template was 
Results
To evaluate the EBP project's success, EMR data were analyzed. There were 110 dysuria visits over the implementation period (September 1 to November 30, 2016). Table 1 summarizes the amount of CHL pre-screening done pre and post intervention in dysuria visits in a control chart. The post-intervention period showed a significant desirable trend in CHL pre-screening rates. In the post intervention period, there were no missed opportunities to pre-screen for CHL.
In other words, of the 110 dysuria visits, 100% received CHL pre-screening. The preintervention or baseline period showed a significantly undesirable trend in CHL pre-screening rates. There were 96% missed opportunities to pre-screen and ultimately screen for CHL in the baseline period. Table 1 . CHL Pre-Screening Rate in Dysuria Visits Table 2 shows the CHL pre-screening alert breakdown of the 110 dysuria visits in a bar chart. The amount of women not indicated for CHL screening was nearly 51%. The amount of women indicated for CHL screening was 49%. Approximately 54 % of the women indicated for CHL screening declined testing. The other or delayed screening option was nearly 8% of the women indicated. The indicated and ordered option accounted for about 30% of the women indicated for CHL screening.
There were 16 CHL screenings/tests ordered from the 110 dysuria visits. This was about a 9% increase in CHL screenings/tests ordered from the baseline period. Table 2 also summarizes the amount of patients educated on the CDC CHL screening guidelines. Specifically, of the 110 dysuria visits, 29% of the women were educated about CHL screening. The ethnicity of the 110 women pre-screened for CHL were 56% Caucasian, 20%
Hispanic, 10% multi-racial, 8% Asian, 6% of an unknown race. Of the 16 CHL screenings ordered, 56% were from Caucasian females, 19% from multi-racial females, 13% from Asian females, 6% from Hispanic females, and 6% from females of an unknown race. Women age 21
had the highest number of CHL pre-screenings followed by age 20, 22, 19, 18, 23, and 24. Of the 16 CHL screenings ordered, women age 20 accounted for the most CHL screenings followed by age 22, 18, 19, 21, 23, and 24.
Discussion
Implications for Practice
There are several implications for practice after implementing this EBP project and analyzing the data. Increasing CHL pre-screening was associated with increased CHL screening rates. The increased screening may prevent the spread of CHL at the university and in the community. By early recognition of CHL in the two positive cases, this could have likely prevented PID and infertility related costs for these two patients. Specific parts of the EBP program may translate well and be used at other SHCs. The mandatory pre-screening alerts were especially useful in increasing CHL screening because they could not be avoided in the encounter note. The pre-screening alerts had to be completed before discharge. This EMR change was relatively simple and had a significant impact on the amount of CHL screenings ordered. This project showed EMR alerts are an effective way to remind staff to screen for CHL during dysuria visits.
It is important to investigate further some aspects of the program. It would be interesting to explore why some women declined CHL screening and if they declined, was screening education offered. Another aspect to investigate would be if the provider chose the other/delayed option of the pre-screening alerts, did this population of women ever receive CHL screening. To know the barriers and reasons for declination may ultimately help increase CHL screening at the SHC. Also there were three types of screening tests offered (urine, self-collected vaginal swab and cervical swab). The numbers of specific type of screening tests were not collected. It may be beneficial for the site to collect this data to see what test was used most and if this method was cost effective and feasible for the site. It would also be interesting to explore if the provider or the patient preferred one method of testing. Finally, for the women that were not indicated for screening, it would be interesting to separate the amount of women who were not sexually active from the amount of women who received CHL screening within the past year.
The next steps for the project site would be to implement the mandatory pre-screening EMR alerts in other visit templates. These visit templates could include annual physical exams, well women exams, vaginitis, and of course visits directly related to sexually transmitted infection screening. Also the leadership of SHC could reeducate SHC staff to use the education option in the plan section of the encounter note. This could increase the amount of women educated on CDC CHL screening guidelines.
Conclusions
The EBP project met the goal to increase CHL pre-screening and screening in women under age 25 who presented to the SHC with urinary symptoms. The EBP project outcomes were consistent with the evidence to both screen for CHL in this age group and to use specific interventions to increase screening. The practice changes made are a sustainable addition to the EMR at the SHC especially the mandatory pre-screening alerts. The efforts made by this project support the USPSTF and CDC guidelines.
